ArticleBriefings in bioinformatics2025
Toward high-efficiency, low-resource, and explainable neuropeptide prediction with MSKDNP.
Article in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- A generative explainable model for antimicrobial peptide prediction using bidirectional temporal convolutional neural network.Scientific reports · 2026Article
- DeepStackVEGF a stacking ensemble deep learning framework for vascular endothelial growth factor prediction.Scientific reports · 2026Article
- De novo generation and in silico screening of anti-diabetic peptide candidates via a deep learning-attention framework with physicochemical feature fusion.Scientific reports · 2026Article
- The role of the cardiac lymphatic system in heart failure "reverse remodeling": from developmental signals to druggable targets.Frontiers in immunology · 2026Review
- Autophagy: mechanisms, roles in human diseases, and therapeutic perspectives.Frontiers in cell and developmental biology · 2026Review
- Bioactive peptides targeting dyslipidemia and atherosclerosis: from computational discovery and data bottlenecks to precision medicine translation.Frontiers in molecular biosciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Neuropeptides are essential signaling molecules produced in the nervous system that regulate diverse physiological processes and are closely implicated in the pathogenesis of neurodegenerative and neuropsychiatric disorders. Investigating neuropeptides contributes to a better understanding of their regulatory mechanisms and offers new insights into therapeutic strategies for related diseases. Therefore, accurate identification of neuropeptides is crucial for advancing biomedical research and drug development. Due to the high cost of experimental validation, various artificial intelligence methods have been developed for rapid neuropeptide identification. However, existing approaches often suffer from high computational resource consumption, slow processing speed, and poor deploy ability. Moreover, a user-friendly web server for practical application is still lacking. To this end, we propose MSKDNP, a neuropeptide prediction model based on a multi-stage knowledge distillation framework. With only 1.2% of the parameters, MSKDNP attains performance comparable to a fully fine-tuned protein language model while achieving state-of-the-art results in neuropeptide recognition. Moreover, MSKDNP provides favorable interpretability, facilitating biological understanding. A freely accessible web server is available at https://awi.cuhk.edu.cn/∼biosequence/MSKDNP/index.php.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.